Skip to main content
Signal8

Lacey John III

SEC insider (Form 3/4/5 filer). CIK 0001739761. Director at PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2024. Located in KNOXVILLE, TN.

Companies Lacey John III has filed insider reports for

  • PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT): Director
Lacey John III profile photo

Lacey John III

CIK: 0001739761

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PROVECTUS BIOPHARMACEUTICALS, INC. logo
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • PROVECTUS BIOPHARMACEUTICALS, INC. logo
    PVCT

    PROVECTUS BIOPHARMACEUTICALS, INC.

    Dec 2, 2024
    Award

    Stock Options (Right to Buy)

    Direct
    775.1K shares-
  • PROVECTUS BIOPHARMACEUTICALS, INC. logo
    PVCT

    PROVECTUS BIOPHARMACEUTICALS, INC.

    Sep 30, 2024
    Award

    Series D-1 Convertible Preferred Stock

    Direct
    179.6K shares-

1-2 of 2